Mizuho Medy

4595.TTSE STANDARDPharmaceutical

Key numbers · FY ended 2025-12

Revenue¥11.3bn-1.5% YoY Operating income¥4.6bn-5.5% YoY Total assets¥22.4bn+7.9% YoY EPS (basic)¥179.84-9.2% YoY

Full financial history and reports →

Stock price4595 · View chart ↗

Open the price chart on TradingView.

Latest filings

Thu, Mar 12 · JST1 filing

17:07MATERIALMizuho Medy · Change of representative director

Mon, Jan 6 · JST1 filing

16:195% STAKEMizuho Medy · Fuminari Karakawa + 1 joint holder · 22.96% → 20.99%−1.97pp

Tue, Dec 10 · JST1 filing

09:455% STAKEMizuho Medy · Fuminari Karakawa + 1 joint holder · 36.83% → 22.96%−13.87pp

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
Fuminari Karakawa	20.99%	-1.97pp	2025-01-06

Each holder's own ratio from its most recent large-shareholding report.